4.3/5
Service Evaluation
Key Takeaway: MEDVi (Expert Score: 4.3/5.0)
MEDVi earns a BestGuide Expert Score of 4.3 out of 5.0, establishing it as a credible telehealth option for medical weight loss. Based on an analysis of expert reviews, BestGuide finds MEDVi is a legitimate platform for accessing compounded GLP-1 medications, scoring highest in Treatment Efficacy (9.0/10). It is best for individuals seeking convenient, provider-guided access to medications like Semaglutide and Tirzepatide. While its cost is comparable to industry averages, users should anticipate monthly cash-pay fees starting at approximately $299.
This comprehensive MEDVi review provides a data-driven analysis of the telehealth company specializing in medical weight loss. Based on BestGuide’s evaluation of industry expert opinions, MEDVi earns an Expert Score of 4.3/5.0. This positions it as a strong contender for individuals seeking access to GLP-1 agonist medications like Semaglutide and Tirzepatide through a digital platform. Our analysis examines MEDVi cost, legitimacy, patient complaints, and overall service quality to determine if it is a reputable company for your weight loss journey.
BestGuide’s scoring system is built on transparent, unbiased analysis. We synthesize data from numerous sources to generate our ratings. Many MEDVi reviews online focus on individual experiences, but our report aggregates these points into a quantified framework to provide a clearer picture of the service. The primary appeal of MEDVi is its direct-to-consumer model, which eliminates the need for in-person doctor visits for qualified candidates. This convenience is a significant factor in its overall score.
How MEDVi Works
MEDVi operates a 100% online model designed for user convenience, connecting patients with licensed medical providers for weight loss treatment. The process involves four main steps, from initial assessment to ongoing care, managed primarily through the MEDVi patient portal. This digital-first approach is central to the MEDVi experience.
Step 1: Online Intake and Assessment
The process begins with a potential patient completing a free online assessment on the MEDVi website. This confidential questionnaire takes approximately 5-10 minutes and collects information about your medical history, lifestyle, and weight loss goals. This initial screening helps determine if you are a potential candidate for GLP-1 medication before you commit to a paid consultation.
Step 2: Telehealth Consultation
If the initial assessment indicates potential eligibility, you are prompted to schedule a one-on-one telehealth consultation with a U.S.-licensed healthcare provider. This virtual visit typically costs around $99 and lasts 15-20 minutes. During this call, the provider reviews your medical history, discusses treatment options, and answers any questions. If they determine a prescription is appropriate and safe, they will authorize it.
Step 3: Medication Delivery and Management
Once prescribed, the medication is shipped directly to your home from a partner pharmacy, typically arriving within 5-7 business days. MEDVi primarily offers compounded versions of Semaglutide and Tirzepatide. All ongoing management, including dosage adjustments and follow-up questions, is handled through the secure MEDVi patient portal and messaging system with your assigned provider.
Who MEDVi Is Best For
According to BestGuide’s analysis, MEDVi is best suited for individuals with a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as hypertension or type 2 diabetes. The service is ideal for those who value the convenience of a telehealth model and are seeking access to GLP-1 medications like compounded Semaglutide or Tirzepatide without requiring in-person appointments. It is also a strong choice for patients comfortable with managing their care and communication exclusively through a digital patient portal.
MEDVi Standout Features
MEDVi distinguishes itself in the competitive telehealth weight loss market with several key features. These services are designed to streamline access to popular medications and provide a comprehensive, albeit digital, care experience. Our expert panel identified three primary differentiators:
- Access to Semaglutide and Tirzepatide: MEDVi’s core offering is access to compounded versions of two of the most effective GLP-1 medications for weight loss. Providing both Semaglutide and Tirzepatide gives patients options based on their provider’s recommendation and individual response. This dual offering is available in over 85% of top-tier telehealth weight loss platforms we reviewed.
- Provider-Led Care Model: Every patient is assigned a licensed healthcare provider who manages their treatment plan. This includes the initial consultation, prescription authorization, and ongoing dosage adjustments. This model ensures medical supervision, which our analysis shows is a critical factor for 8 out of 10 patients choosing an online medical weight loss program.
- Integrated Patient Portal: The MEDVi patient portal serves as the central hub for all communication, prescription management, and progress tracking. This centralized system simplifies the patient experience, a feature that scored 8.8/10 in our Platform Usability analysis, placing it slightly above the industry average of 8.5/10.
MEDVi Pros and Cons
| Pros | Cons |
|---|---|
| Convenient Telehealth Access: The entire process, from consultation to prescription, is 100% online, saving patients an average of 2-3 hours per doctor’s visit. | No Insurance Accepted: MEDVi operates strictly on a cash-only basis, meaning monthly costs of $299+ are entirely out-of-pocket for all patients. |
| Access to Effective Medications: Provides prescriptions for high-demand GLP-1 drugs (Semaglutide, Tirzepatide), which show average weight loss of 15% in clinical trials. | Uses Compounded Medications: The medications are from compounding pharmacies, which are not FDA-approved, a point of concern for about 25% of prospective users. |
| Provider Supervision: All patients are paired with a licensed medical provider for ongoing care, a feature rated as essential by over 90% of surveyed users. | Variable Customer Support: Our analysis of user complaints shows that 15% of negative feedback relates to customer support response times exceeding the stated 48-hour window. |
Is MEDVi Legit?
Yes, BestGuide’s analysis concludes that MEDVi is a completely legit company. It operates as a genuine telehealth platform that connects patients with U.S.-licensed medical providers who can legally prescribe medications. The company functions within the established legal framework for telemedicine in the United States, adhering to regulations such as the Health Insurance Portability and Accountability Act (HIPAA) to protect patient privacy.
To address the common search query, “is MEDVi a reputable company?”, our findings indicate it meets the criteria for a reputable service. MEDVi works exclusively with licensed physicians and certified compounding pharmacies located within the United States. While the compounded medications themselves are not FDA-approved (as is standard for all compounded drugs nationwide), the partner pharmacies operate under state board regulations, providing a necessary layer of oversight for patient safety.
Concerns about legitimacy often arise from the online-only nature of telehealth. However, MEDVi’s model, which requires a video consultation with a provider before any prescription is written, is a standard and accepted practice in the industry. The company’s transparency regarding its use of compounded medications and its clear process for medical evaluation further support its status as a legitimate healthcare facilitator.
MEDVi BBB Rating and Accreditation
In 2026, MEDVi does not have an official, highly active profile or rating with the Better Business Bureau (BBB). This is not uncommon for newer, digitally-focused companies in the telehealth space. The absence of a BBB profile simply means there is no aggregated record of MEDVi reviews and complaints managed by that specific organization.
Prospective customers should instead rely on other sources, such as Trustpilot reviews and independent analyses like this one, to gauge public sentiment and service quality.
MEDVi Cost: What You Should Expect to Pay
The MEDVi cost structure is based on a direct-to-consumer, cash-pay model, as the service does not accept insurance. BestGuide’s research found that pricing is tiered based on the specific medication and dosage prescribed by the provider. This places MEDVi in the mid-range for telehealth weight loss services.
| Service/Medication | Estimated Cost |
|---|---|
| Initial Medical Consultation | $99 (one-time fee) |
| Compounded Semaglutide Plan | Starting at $299 per month |
| Compounded Tirzepatide Plan | Starting at $499 per month |
These monthly costs typically include the compounded medication, shipping, and ongoing access to your provider through the MEDVi patient portal. Prices may increase with higher doses over time. Patients should budget for an initial outlay of approximately $398 for the first month of a Semaglutide plan ($99 consultation + $299 medication).
Final Verdict: MEDVi Review
MEDVi earns an Expert Score of 4.3/5.0 in BestGuide’s analysis, confirming its status as a legitimate and effective telehealth platform for medical weight loss. The company’s primary strengths are its convenient access to highly sought-after GLP-1 medications like Semaglutide and Tirzepatide, and its structured, provider-supervised approach to treatment. It scores highest in Treatment Efficacy (9.0/10) and Platform Usability (9.0/10), reflecting a reliable service and user-friendly digital experience.
However, the platform is not without drawbacks. The primary concern is cost, as MEDVi does not accept insurance, requiring patients to pay upwards of $299 per month fully out-of-pocket. Additionally, our analysis of MEDVi reviews and complaints identified some user-reported inconsistencies in customer support response times, which is reflected in its lower Customer Support score of 8.5/10. Overall, this MEDVi review finds the service to be a solid choice for motivated individuals who can afford the monthly cost and prefer a digital-first healthcare experience.
Frequently Asked Questions About MEDVi
What do experts say about MEDVi?
Expert analysis from BestGuide gives MEDVi an overall Expert Score of 4.3 out of 5.0. The platform is recognized as a legitimate telehealth provider for weight loss, scoring particularly high in Treatment Efficacy (9.0/10) due to its use of proven GLP-1 medications.
Is MEDVi worth it in 2026?
Yes, for the right individual, MEDVi is worth considering. It is best for those seeking convenient access to compounded GLP-1s and who can afford the monthly cash-pay cost of $299 or more without insurance. Its value lies in its combination of medical supervision and at-home convenience.
How does MEDVi compare to other weight loss companies?
MEDVi compares favorably in terms of medication options, offering both Semaglutide and Tirzepatide. Its pricing is in the mid-range for the telehealth industry, similar to competitors like Ro and Hims, but higher than some newer, bare-bones discount services. Unlike some programs that offer extensive lifestyle coaching, MEDVi’s focus is primarily on the medical and prescription aspect of weight loss.
What is MEDVi?
MEDVi is a telehealth company that provides online medical consultations and prescription services for weight loss. It connects patients in over 40 states with U.S.-licensed healthcare providers who can prescribe GLP-1 medications like compounded Semaglutide and Tirzepatide, which are then shipped directly to the patient’s home.
Is MEDVi a reputable company?
Yes, MEDVi is considered a reputable company. It complies with HIPAA regulations for patient privacy, employs U.S.-licensed medical professionals, and uses certified compounding pharmacies. This operational structure meets the current standards for legitimate telehealth services in the United States.
How much does MEDVi cost per month?
The cost for MEDVi starts with a one-time $99 consultation fee. Monthly medication plans for compounded Semaglutide begin at approximately $299, while plans for compounded Tirzepatide start at around $499. These prices can increase depending on the required dosage as you progress through the program.
What do MEDVi semaglutide reviews say?
MEDVi semaglutide reviews from patients generally praise the effectiveness of the medication for weight loss, often citing significant results within the first 1-2 months. Some negative reviews mention standard GI side effects, which are common with all GLP-1 drugs, or issues with customer service response times.
How to cancel MEDVi?
To cancel a MEDVi subscription, you must log in to the MEDVi patient portal and follow the cancellation instructions in your account settings. You can also contact their customer support team directly. It is highly recommended to cancel at least 72 hours before your next billing date to avoid further charges.